Next 10 |
home / stock / enov / enov articles
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
Enovis Corporation’s (NYSE:ENOV) fourth-quarter net sales reached $455 million, up 11% Y/Y, including 8% organic growth, beating the con...
William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market va...
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising the price target to $70 from ...
Brady R. Shirley, current President and COO, to retire effective April 1, 2025. Louie Vogt to be promoted to Group President of Reconstructive se...
Wilmington, DE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth compan...
Wilmington, DE, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV, "Enovis" or the "Company")) today announced the pricing...
Enovis Corporation (NYSE: ENOV) shares are trading lower on Thursday after the company announced a proposed private offering of $400 million of con...
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV, "Enovis" or the "Company")) today announced its intenti...
News, Short Squeeze, Breakout and More Instantly...
Enovis Corporation Company Name:
ENOV Stock Symbol:
NYSE Market:
Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Bank of America Healthcare Conference: Ben ...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...